About ADAPT Pharma
ADAPT Pharma is a company based in Dublin (Ireland) founded in 2014 by Seamus Mulligan and David Brabazon was acquired by Emergent BioSolutions in August 2018. ADAPT Pharma operates in a competitive market with competitors including Indivior, Biotie, Ethypharm, Braeburn and Opiant Pharmaceuticals, among others.
- Headquarter Dublin, Ireland
- Founders Seamus Mulligan, David Brabazon
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
Not available
- Investors
-
Employee Count
Not available
-
Acquired by
Emergent BioSolutions
(Aug 28, 2018)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of ADAPT Pharma
Detailed funding history for ADAPT Pharma
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investors in ADAPT Pharma
ADAPT Pharma has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Emergent BioSolutions.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Vaccines for viral infections are developed by the company.
|
Locked | Locked | Locked |
Investor details for ADAPT Pharma
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by ADAPT Pharma
Investment portfolio details for ADAPT Pharma
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - ADAPT Pharma
Detailed financials for ADAPT Pharma
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Adapt Pharma Comparisons
Peer comparison for ADAPT Pharma
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of ADAPT Pharma
ADAPT Pharma operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Indivior, Biotie, Ethypharm, Braeburn and Opiant Pharmaceuticals, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Therapeutics for opioid addiction treatment are developed and commercialized.
|
|
| Locked | Locked | Locked |
Drugs for neurodegenerative and psychiatric disorders are developed by Biotie.
|
|
| Locked | Locked | Locked |
Therapies for pain and addiction treatment are developed.
|
|
| Locked | Locked | Locked |
Long-acting therapies for opioid addiction and chronic pain are developed.
|
|
| Locked | Locked | Locked |
Therapeutics for addictive and eating disorders are developed.
|
|
| Locked | Locked | Locked |
Therapies for substance use disorders are developed by Amygdala Neurosciences.
|
Detailed competitors of ADAPT Pharma
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Adapt Pharma
Complete news archive for ADAPT Pharma
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about ADAPT Pharma
ADAPT Pharma was founded in 2014.
ADAPT Pharma is headquartered in Dublin, Ireland.
Seamus Mulligan is the current CEO of ADAPT Pharma. They have also founded this company.
ADAPT Pharma was founded in 2014 in Dublin, Ireland, within the pharmaceutical sector. Emergency therapeutic conditions are addressed through the development of opioid antagonist therapies. The lead candidate, NARCAN (naloxone HCl), has been reformulated as a nasal spray for treating opioid overdoses. Fast Track Designation and priority review have been granted to this product by regulatory authorities.
ADAPT Pharma's top competitors include Indivior, Ethypharm and Amygdala Neurosciences.
ADAPT Pharma has 1 investor. Key investors include Emergent BioSolutions.